Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

Ryan Stevenson; Steven K. Libutti; Muhammad Wasif Saif

Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

Ryan Stevenson, Steven K. Libutti, Muhammad Wasif Saif

Surgery

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

Original language	English (US)
Pages (from-to)	155-157
Number of pages	3
Journal	Journal of the Pancreas
Volume	14
Issue number	2
State	Published - Mar 1 2013

Keywords

Biological markers
Gastro-enteropancreatic neuroendocrine tumors
Human
PHLPP2 protein
Succinate dehydrogenase

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Hepatology
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013. / Stevenson, Ryan; Libutti, Steven K.; Saif, Muhammad Wasif.
In: Journal of the Pancreas, Vol. 14, No. 2, 01.03.2013, p. 155-157.

Research output: Contribution to journal › Article › peer-review

@article{7578da89b22d4fbf80be561020f4e6ed,

title = "Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the {"}2013 ASCO gastrointestinal cancers symposium{"}. San Francisco, CA, USA. january 24-26, 2013",

abstract = "Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.",

keywords = "Biological markers, Gastro-enteropancreatic neuroendocrine tumors, Human, PHLPP2 protein, Succinate dehydrogenase",

author = "Ryan Stevenson and Libutti, {Steven K.} and Saif, {Muhammad Wasif}",

year = "2013",

month = mar,

day = "1",

language = "English (US)",

volume = "14",

pages = "155--157",

journal = "Journal of the Pancreas",

issn = "1590-8577",

publisher = "E.S. Burioni Ricerche Bibliografiche",

number = "2",

}

TY - JOUR

T1 - Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors

T2 - Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

AU - Stevenson, Ryan

AU - Libutti, Steven K.

AU - Saif, Muhammad Wasif

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

AB - Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

KW - Biological markers

KW - Gastro-enteropancreatic neuroendocrine tumors

KW - Human

KW - PHLPP2 protein

KW - Succinate dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=84875043116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875043116&partnerID=8YFLogxK

M3 - Article

C2 - 23474561

AN - SCOPUS:84875043116

SN - 1590-8577

VL - 14

SP - 155

EP - 157

JO - Journal of the Pancreas

JF - Journal of the Pancreas

IS - 2

ER -

Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this